Adjuvant FOLFOX treatment for stage III colon cancer: how many cycles are enough?

PURPOSE: Adjuvant FOLFOX (5-fluorouracil and oxaliplatin) chemotherapy benefits stage III colon cancer patients. However, it still results in side effects and increased cost. Reducing cycles had been thought to decrease these problems. This retrospective study aimed to find the appropriate number of...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Springerplus
Hoofdauteurs: Tsai, Yi-Jian, Lin, Jen-Kou, Chen, Wei-Shone, Jiang, Jeng-Kai, Teng, Hao-Wei, Yen, Chueh-Chuan, Lin, Tzu-chen, Yang, Shung-Haur
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Springer International Publishing 2016
Onderwerpen:
Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4980863/
https://ncbi.nlm.nih.gov/pubmed/27563513
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40064-016-2976-9
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items